PLoS ONE (Jan 2011)

The SOS pilot study: a RCT of routine oxygen supplementation early after acute stroke--effect on recovery of neurological function at one week.

  • Christine Roffe,
  • Khalid Ali,
  • Anushka Warusevitane,
  • Sheila Sills,
  • Sarah Pountain,
  • Martin Allen,
  • John Hodsoll,
  • Frank Lally,
  • Peter Jones,
  • Peter Crome

DOI
https://doi.org/10.1371/journal.pone.0019113
Journal volume & issue
Vol. 6, no. 5
p. e19113

Abstract

Read online

UnlabelledMild hypoxia is common after stroke and associated with poor long-term outcome. Oxygen supplementation could prevent hypoxia and improve recovery. A previous study of routine oxygen supplementation showed no significant benefit at 7 and 12 months. This pilot study reports the effects of routine oxygen supplementation for 72 hours on oxygen saturation and neurological outcomes at 1 week after a stroke.MethodsPatients with a clinical diagnosis of acute stroke were recruited within 24 h of hospital admission between October 2004 and April 2008. Participants were randomized to oxygen via nasal cannulae (72 h) or control (room air, oxygen given only if clinically indicated). Clinical outcomes were assessed by research team members at 1 week. Baseline data for oxygen (n = 148) and control (n = 141) did not differ between groups.ResultsThe median (interquartile range) National Institutes of Health Stroke Scale (NIHSS) score for the groups at baseline was 6 (7) and 5 (7) respectively. The median Nocturnal Oxygen Saturation during treatment was 1.4% (0.3) higher in the oxygen than in the control group (pConclusionOur data show that routine oxygen supplementation started within 24 hours of hospital admission with acute stroke led to a small, but statistically significant, improvement in neurological recovery at 1 week. However, the difference in NIHSS improvement may be due to baseline imbalance in stroke severity between the two groups and needs to be confirmed in a larger study and linked to longer-term clinical outcome.Trial registrationControlled-Trials.com ISRCTN12362720; European Clinical Trials Database 2004-001866-41.